Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Irma Bagdoniene: Lowering LDL May Alter Inflammatory and Oxidative Pathways
Irma Bagdoniene/LinkedIn
Oct 20, 2025, 06:22

Irma Bagdoniene: Lowering LDL May Alter Inflammatory and Oxidative Pathways

Irma Bagdoniene, Cardiologist and Lipidologist at Klinikum Lippe – University Hospital for Cardiology, Angiology, and Internal Intensive Care Medicine, posted on LinkedIn:

“Lowering lipids — but increasing oxidation?

A new study by Koutsogianni et al. (2025) looked at people with high Lp(a) and found something unexpected:
– Statins and ezetimibe raised oxidized phospholipids on apoB and apo(a), reduced those on plasminogen,
– while PCSK9 inhibitors had no clear effect.

So even when we lower LDL cholesterol, other inflammatory and oxidative processes may change in ways we don’t yet understand.

The message is clear: we need more studies to understand how lipid-lowering therapies truly affect the biology of Lp(a).”

Title: Effect of lipid-lowering medications on oxidized phospholipids in individuals with elevated LIPOPROTEIN(a)

Authors: Amalia Despoina Koutsogianni, Fotios Barkas, Constantinos Tellis, Alexandros Tselepis, George Liamis, Sotirios Tsimikas, Evangelos Liberopoulos

Irma Bagdoniene

Read full article here.

Stay updated with Hemostasis Today.

Alexandros Tselepis Amalia Despoina Koutsogianni Cholesterol Constantinos Tellis Evangelos Liberopoulos Fotios Barkas George Liamis Hematology Hemostasis Hemostasis Today Irma Bagdoniene LDL Lipid-Lowering Medications Oxidative Processes Oxidized Phospholipids Plasminogen Sotirios Tsimikas
NewsFeed